Ryan is currently Founder and CEO of Bios Life, Ryan is a seasoned healthcare executive with extensive experience in biotechnology, strategic leadership, AI and oncology, as well as a strong track record in fundraising and corporate development.

Prior to this, during his seven years as Chief Strategy Officer and Executive Board Member of BioNTech, he helped lead the company through its Series B financing, NASDAQ IPO and subsequent public financings, which raised more than $1 billion in equity capital. He played a key role in BioNTech’s international growth, corporate strategy and oncology portfolio, and was closely involved in its transformation from a private clinical-stage biotech into a global, publicly listed biotechnology company.

Ryan also served as Chairman of InstaDeep following its acquisition by BioNTech, bringing further experience at the intersection of AI, machine learning and life sciences. He was previously an Executive Director in J.P. Morgan’s global healthcare investment banking team for over eight years, advising on numerous equity and debt financings and more than 25 cross-border M&A transactions worth over $100 billion. Early in his career, Ryan served on the founding team of Quantitative Insights, which received FDA approval for a machine-learning system for breast cancer diagnosis.

He currently also serves as a Non-Executive Director at Autolus Therapeutics and Linden Lake Labs.